We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+8.78%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$9.66B
AUM Growth
+$1.09B
Cap. Flow
+$606M
Cap. Flow %
6.27%
Top 10 Hldgs %
17.35%
Holding
548
New
171
Increased
100
Reduced
111
Closed
146

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$302M
2
CRM icon
Salesforce
CRM
+$147M
3
GTLS
Chart Industries
GTLS
+$118M
4
TEAM icon
Atlassian
TEAM
+$110M
5
NKE icon
Nike
NKE
+$99.2M

Top Sells

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$253M
2
SAP icon
SAP
SAP
+$151M
3
CIEN icon
Ciena
CIEN
+$115M
4
SHOP icon
Shopify
SHOP
+$105M
5
ILMN icon
Illumina
ILMN
+$103M

Sector Composition

Rank Sector Weight
1 Technology 23.86%
2 Healthcare 15.66%
3 Industrials 12.67%
4 Consumer Discretionary 10.33%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANTX icon
376
AN2 Therapeutics
ANTX
$213M
$462K ﹤0.01%
48,426
-57,292
-54% -$767K
AFMD
377
DELISTED
Affimed
AFMD
$434K ﹤0.01%
35,000
– –
HOWL icon
378
Werewolf Therapeutics
HOWL
$18.6M
$423K ﹤0.01%
206,201
– –
RYM
379
RYTHM Inc
RYM
$47.7M
$411K ﹤0.01%
+4,113
New +$2.65M
FBIN icon
380
Fortune Brands Innovations
FBIN
$5.73B
$406K ﹤0.01%
7,108
-105,578
-94% -$5.55M
PRDS
381
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$380K ﹤0.01%
225,000
– –
HZNP
382
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$354K ﹤0.01%
+3,113
New +$259K
MTZ icon
383
MasTec
MTZ
$21.5B
$335K ﹤0.01%
3,928
-430,918
-99% -$35.3M
TCRT icon
384
Alaunos Therapeutics
TCRT
$4.84M
$325K ﹤0.01%
+3,333
New +$483K
GB.WS
385
DELISTED
Global Blue Group Holding AG Warrants exercisable for one Ordinary Share of Global Blue Group Holding AG at a price of $11.50 per share
GB.WS
$320K ﹤0.01%
+1,050,188
New +$261K
DG icon
386
Dollar General
DG
$27B
$311K ﹤0.01%
+1,262
New +$312K
MDNA
387
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$298K ﹤0.01%
650,000
– –
ATNX
388
DELISTED
Athenex, Inc. Common Stock
ATNX
$295K ﹤0.01%
100,000
– –
AYTU icon
389
AYTU BioPharma
AYTU
$25.5M
$284K ﹤0.01%
75,000
– –
CDAK
390
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$265K ﹤0.01%
666,891
-65,702
-9% -$43.2K
SOC.WS
391
DELISTED
Sable Offshore Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
SOC.WS
$262K ﹤0.01%
+370,508
New +$172K
OPAL icon
392
OPAL Fuels
OPAL
$78.9M
$255K ﹤0.01%
+35,000
New +$282K
ETWO.WS
393
DELISTED
E2open Parent Holdings, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50
ETWO.WS
$246K ﹤0.01%
+292,328
New +$245K
EQIX icon
394
Equinix
EQIX
$103B
$231K ﹤0.01%
353
-13,762
-97% -$8.5M
AURA icon
395
Aura Biosciences
AURA
$796M
$225K ﹤0.01%
+21,456
New +$273K
GETR
396
DELISTED
Getaround, Inc.
GETR
$212K ﹤0.01%
+325,000
New +$2.49M
CTOS.WS
397
DELISTED
Custom Truck One Source, Inc. Warrants, exerciseable for Common Stock
CTOS.WS
$200K ﹤0.01%
+479,592
New +$323K
SRZN icon
398
Surrozen
SRZN
$295M
$178K ﹤0.01%
20,377
– –
LOCL icon
399
Local Bounti
LOCL
$26.2M
$175K ﹤0.01%
9,677
-1,034
-10% -$32.3K
HYFM icon
400
Hydrofarm Holdings
HYFM
$9.29M
$155K ﹤0.01%
10,000
-82,482
-89% -$1.88M
14 15
16
17 18

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q4 2022 Portfolio in Review

As of Q4 2022, Alyeska Investment Group held 548 positions worth $9.66B, up 13% from $8.58B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Alyeska Investment Group deployed $606M of net new capital in Q4 2022, opening 171 new positions and adding to 100 existing holdings. Its largest new stake was Chart Industries: 737,397 shares worth $85M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Adobe, an estimated $253M trimmed.

  • Alyeska Investment Group's largest Q4 2022 buy was Chart Industries: 737,397 shares worth $85M.
  • Alyeska Investment Group added most to Meta Platforms (Facebook) in Q4 2022, an estimated $302M increase.
  • Alyeska Investment Group's biggest Q4 2022 reduction was Adobe, cutting an estimated $253M.
  • Alyeska Investment Group fully exited Shopify in Q4 2022, selling an estimated $105M.
  • Alyeska Investment Group's ten largest holdings make up 17% of its $9.66B portfolio in Q4 2022.
  • Alyeska Investment Group opened 171 new positions and closed 146 in Q4 2022.
  • Alyeska Investment Group's portfolio value rose 13% quarter-over-quarter to $9.66B.

Based on Alyeska Investment Group's 13F filing for Q4 2022, filed 14 Feb 2023.